Literature DB >> 15196256

Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.

H Ayukawa1, T Matsubara, M Kaneko, M Hasegawa, T Ichiyama, S Furukawa.   

Abstract

Influenza virus and respiratory syncytial virus (RSV) are the most common causes of acute severe respiratory infection in children during the winter. There have been few reports about peripheral blood T cell activation in vivo in influenza virus infection and conflicting results concerning peripheral blood T cells activation in RSV infection. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4, CD152) is a receptor present on T cells that plays a critical role in the down-regulation of antigen-activated immune responses. To clarify the status of peripheral blood T cells, we investigated intracellular CTLA-4 expression in T cells in patients with influenza virus and RSV infection. We collected blood samples from 15 patients with influenza virus infection, including three with complications of influenza virus-associated encephalopathy and 18 patients with RSV infection, as well as 44 healthy children. We determined the intracellular expression of CTLA-4 in CD4+ and CD8+ T cells by flow cytometry. There were no significant differences in the percentages of intracellular CTLA-4-positive CD4+ T cells and CD8+ T cells by age. The percentages of intracellular CTLA-4-positive CD4+ T cells in the patients with influenza virus infection were significantly higher than those in healthy children (P < 0.01). In particular, the patients with influenza virus-associated encephalopathy had sevenfold higher percentages of CTLA-4-positive CD4+ T cells than influenza patients without encephalopathy (P < 0.05). The patients with influenza virus-associated encephalopathy had increased percentages of CTLA-4-positive CD8+ cells at the acute stage in comparison with the convalescent stage and in control subjects (P < 0.01, respectively). RSV patients showed no increase in CTLA-4-positive CD4+ T cells or CD8+ T cells. The immunological status of peripheral T cell activation is substantially different in influenza virus infection and RSV infection. The patients with RSV infection did not show any increase in CTLA-4-positive peripheral blood T cells. There was a remarkable increase in intracellular CTLA-4 in CD4+ and CD8+ T cells in influenza virus-associated encephalopathy. Down-regulation of antigen-activated peripheral blood T cell activation might play an important role in the pathogenesis of influenza virus-associated encephalopathy and host defence against influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196256      PMCID: PMC1809088          DOI: 10.1111/j.1365-2249.2004.02502.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

Review 1.  RSV-induced immunopathology: dynamic interplay between the virus and host immune response.

Authors:  Steven M Varga; Thomas J Braciale
Journal:  Virology       Date:  2002-04-10       Impact factor: 3.616

2.  Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages.

Authors:  S Matikainen; J Pirhonen; M Miettinen; A Lehtonen; C Govenius-Vintola; T Sareneva; I Julkunen
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

3.  Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection.

Authors:  Robert C Welliver; Roberto P Garofalo; Pearay L Ogra
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129

4.  Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.

Authors:  X B Wang; C Y Zheng; R Giscombe; A K Lefvert
Journal:  Scand J Immunol       Date:  2001-11       Impact factor: 3.487

5.  Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy.

Authors:  Y Ito; T Ichiyama; H Kimura; M Shibata; N Ishiwada; H Kuroki; S Furukawa; T Morishima
Journal:  J Med Virol       Date:  1999-08       Impact factor: 2.327

6.  CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria.

Authors:  T Schlotmann; I Waase; C Jülch; U Klauenberg; B Müller-Myhsok; M Dietrich; B Fleischer; B M Bröker
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

Review 7.  Influenza-associated encephalopathy in Japan.

Authors:  Norio Sugaya
Journal:  Semin Pediatr Infect Dis       Date:  2002-04

8.  Encephalitis and encephalopathy associated with an influenza epidemic in Japan.

Authors:  Tsuneo Morishima; Takehiro Togashi; Shyumpei Yokota; Yoshinobu Okuno; Chiaki Miyazaki; Masato Tashiro; Nobuhiko Okabe
Journal:  Clin Infect Dis       Date:  2002-08-07       Impact factor: 9.079

9.  Different expression of ICAM-1 and LFA-1 alpha by peripheral leukocytes during respiratory syncytial virus and influenza virus infection in young children.

Authors:  M Koga; T Matsuoka; T Matsubara; K Katayama; S Furukawa
Journal:  Scand J Infect Dis       Date:  2000

10.  Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections.

Authors:  P Joshi; A Shaw; A Kakakios; D Isaacs
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

View more
  11 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 2.  Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure.

Authors:  Bradley S Podd; Dennis W Simon; Santiago Lopez; Andrew Nowalk; Rajesh Aneja; Joseph A Carcillo
Journal:  Pediatr Clin North Am       Date:  2017-08-18       Impact factor: 3.278

Review 3.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  Differential CTLA-4 expression in human CD4+ versus CD8+ T cells is associated with increased NFAT1 and inhibition of CD4+ proliferation.

Authors:  D V Chan; H M Gibson; B M Aufiero; A J Wilson; M S Hafner; Q-S Mi; H K Wong
Journal:  Genes Immun       Date:  2013-10-31       Impact factor: 2.676

5.  Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.

Authors:  Michihito Tagawa; Naoya Maekawa; Satoru Konnai; Satoshi Takagi
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

6.  Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.

Authors:  Wafa Khamri; Robin D Abeles; Tie Zheng Hou; Amy E Anderson; Ahmed El-Masry; Evangelos Triantafyllou; Christine Bernsmeier; Fin S Larsen; Arjuna Singanayagam; Nobuaki Kudo; Lucia A Possamai; Fanny Lebosse; Georg Auzinger; William Bernal; Christopher Willars; Christopher J Weston; Giovanna Lombardi; Julia Wendon; Mark Thursz; Charalambos G Antoniades
Journal:  Gastroenterology       Date:  2017-03-28       Impact factor: 22.682

Review 7.  Host Components Contributing to Respiratory Syncytial Virus Pathogenesis.

Authors:  Jonatan J Carvajal; Andrea M Avellaneda; Camila Salazar-Ardiles; Jorge E Maya; Alexis M Kalergis; Margarita K Lay
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

8.  Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1.

Authors:  Na-Na Lu; Qi Liu; Li-Gang Gu; Shi-Jie Ge; Jun Wu; Qiu Ze-Ji; Ze-Ji Qiu; Hong-Chun Zhang; En-Xiang Chao; Zhuo-Nan Yu
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-08       Impact factor: 2.629

9.  FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.

Authors:  Walter Moises Tobias Braga; Bruna Raphaeli da Silva; Ana Carolina de Carvalho; Yumi H Maekawa; Adriana Bruscato Bortoluzzo; Edgar Gil Rizzatti; Djordje Atanackovic; Gisele Wally Braga Colleoni
Journal:  Cancer Immunol Immunother       Date:  2014-08-07       Impact factor: 6.968

10.  Unique human immune signature of Ebola virus disease in Guinea.

Authors:  Paula Ruibal; Lisa Oestereich; Anja Lüdtke; Beate Becker-Ziaja; David M Wozniak; Romy Kerber; Miša Korva; Mar Cabeza-Cabrerizo; Joseph A Bore; Fara Raymond Koundouno; Sophie Duraffour; Romy Weller; Anja Thorenz; Eleonora Cimini; Domenico Viola; Chiara Agrati; Johanna Repits; Babak Afrough; Lauren A Cowley; Didier Ngabo; Julia Hinzmann; Marc Mertens; Inês Vitoriano; Christopher H Logue; Jan Peter Boettcher; Elisa Pallasch; Andreas Sachse; Amadou Bah; Katja Nitzsche; Eeva Kuisma; Janine Michel; Tobias Holm; Elsa-Gayle Zekeng; Isabel García-Dorival; Roman Wölfel; Kilian Stoecker; Erna Fleischmann; Thomas Strecker; Antonino Di Caro; Tatjana Avšič-Županc; Andreas Kurth; Silvia Meschi; Stephane Mély; Edmund Newman; Anne Bocquin; Zoltan Kis; Anne Kelterbaum; Peter Molkenthin; Fabrizio Carletti; Jasmine Portmann; Svenja Wolff; Concetta Castilletti; Gordian Schudt; Alexandra Fizet; Lisa J Ottowell; Eva Herker; Thomas Jacobs; Birte Kretschmer; Ettore Severi; Nobila Ouedraogo; Mar Lago; Anabel Negredo; Leticia Franco; Pedro Anda; Stefan Schmiedel; Benno Kreuels; Dominic Wichmann; Marylyn M Addo; Ansgar W Lohse; Hilde De Clerck; Carolina Nanclares; Sylvie Jonckheere; Michel Van Herp; Armand Sprecher; Gao Xiaojiang; Mary Carrington; Osvaldo Miranda; Carlos M Castro; Martin Gabriel; Patrick Drury; Pierre Formenty; Boubacar Diallo; Lamine Koivogui; N'Faly Magassouba; Miles W Carroll; Stephan Günther; César Muñoz-Fontela
Journal:  Nature       Date:  2016-05-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.